Inflammatory biomarkers for AMD

Advances in Experimental Medicine and Biology

Volumn 801, Issue , 2014, Pages 251-257

  Stanton, Chloe M ^a   Wright, Alan F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Age related macular degeneration; Biomarker; Chemokine; Complement; Cytokine; Inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT BA; COMPLEMENT COMPONENT BB; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR; COMPLEMENT FACTOR D; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG; COMPLEMENT;

AGE RELATED MACULAR DEGENERATION; ARTICLE; COMPLEMENT ACTIVATION; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; IMMUNOLOGY; METABOLISM; PATHOLOGY; RETINA MACULA DEGENERATION; RETINITIS; REVIEW;

BIOLOGICAL MARKERS; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; MACULAR DEGENERATION; RETINITIS;

EID: 84904659602     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3209-8_32     Document Type: Article

References (35)

1. Friedman D, O'Colmain B, Munoz B, Tomany S, McCarty C, Jong P et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564-572
2. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134(3):411-431
3. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H et al (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99(23):14682-14687
4. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH Mullins RF (2001) An integrated hypothesis that considers Drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705-732
5. Zhou J, Jang YP, Kim SR, Sparrow JR (2006) Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci USA 103(44):16182-16187
6. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 99(18):11830-11835
7. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L et al (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14(2):194-198
8. Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF et al (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 18(5):791-798
9. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421-424
10. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102(20):7227-7232
11. Haines JL, Hauser M, Schmidt S, Scott WK, Olson LM, Gallins P et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-421
12. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38(4):458-462
13. Yates JRW, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H et al (2007) Complement C3 Variant and the Risk of Age-Related Macular Degeneration. N Engl J Med 357(6):553-561
14. Heurich M, Martínez-Barricarte R, Francis NJ, Roberts DL, Rodríguez deCS, Morgan BP et al (2011) Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci USA 108(21):8761-8766
15. Hecker LA, Edwards AO, Ryu E, Tosakulwong N, Baratz KH, Brown WL et al (2010) Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 19(1):209-215
16. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50(12):5818-5827
17. Scholl HPN, Issa PC, Walier M, Janzer S, Pollok-kopp B, Fritsche LG et al (2008) Systemic Complement Activation in Age-Related Macular Degeneration. PLoS One 3(7):e2593
18. Stanton CM, Yates JRW, den Hollander AI, Seddon JM, Swaroop A, Stambolian D et al (2011) Complement Factor D in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 52(12):8828-8834
19. Seddon J, Gensler G, Milton R, Klein M, Rifai N (2004) Association between c-reactive protein and age-related macular degeneration. JAMA 291(6):704-710
20. Seddon JM, Gensler G, Rosner B (2010) C-Reactive Protein and CFH ARMS2/HTRA1 Gene Variants Are Independently Associated with Risk of Macular Degeneration. Ophthalmology 117(8):1560-1566
21. Vine AK, Stader J, Branham K, Musch DC, Swaroop A (2005) Biomarkers of Cardiovascular Disease as Risk Factors for Age-Related Macular Degeneration. Ophthalmology 112(12):2076-2080
22. Dasch B, Fuhs A, Behrens T, Meister A, Wellmann J, Fobker M et al (2005) Inflammatory markers in age-related maculopathy: Cross-sectional analysis from the muenster aging and retina study. Arch Ophthalmol 123(11):1501-1506
23. Klein R, Klein BEK, Knudtson MD, Wong TY, Shankar A, Tsai MY (2005) Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 140(1):35-44
24. McGwin G, Hall TA, Xie A, Owsley C (2005) The relation between C reactive protein and age related macular degeneration in the cardiovascular health study. Br J Ophthalmol 89(9):1166-1170
25. Seddon J, George S, Rosner B, Rifai N (2005) Progression of age-related macular degeneration: Prospective assessment of c-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123(6):774-782
26. Langmann T (2007) Microglia activation in retinal degeneration. J Leukoc Biol 81(6): 1345-1351
27. Forrester JV (2003) Macrophages eyed in macular degeneration. Nat Med 9(11):1350-1351
28. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG Cousins SW (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44(8):3586-3592
29. Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J (2003) Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44(8):3578-3585
30. Leung KW, Barnstable CJ, Tombran-Tink J (2009) Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol Immunol 46(7):1374-1386
31. Newman A, Gallo N, Hancox L, Miller N, Radeke C, Maloney M et al (2012) Systemslevel analysis of age-related macular degeneration reveals global biomarkers and phenotypespecific functional networks. Genome Med 4(2):16
32. Jonas J, Tao Y, Neumaier M, Findeisen P (2010) Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 128(10):1281-1286
33. Mo FM, Proia AD, Johnson WH, Cyr D, Lashkari K (2010) Interferon γ-Inducible Protein-10 (IP-10) and Eotaxin as Biomarkers in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 51(8):4226-4236
34. Guymer RH, Tao LW, Goh JK, Liew D, Ischenko O, Robman LD et al (2011) Identification of urinary biomarkers for age-related macular degeneration. Invest Ophthalmol Vis Sci 52(7):4639-4644
35. Grunin M, Burstyn-Cohen T, Hagbi-Levi S, Peled A Chowers I (2012) Chemokine receptor expression in peripheral blood monocytes from patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 53(9):5292-5300